Unraveling the Decline: Search for Factors Behind the Trend in Parkinsons Disease Incidence Rates: A Cohort Study of German Health Claims Data
Fink, A.; Pavlou, M. A.; Roomp, K.; Doblhammer, G.; Schneider, J.
Show abstract
ImportanceSporadic Parkinsons disease (PD) is the second most common neurodegenerative disease in older age. Recent studies have led to a debate regarding trends in incidence and prevalence. ObjectiveWe aimed to investigate age-specific incidence rates of PD and possible explanations for the observed trend in Germany. DesignWe studied two randomly selected longitudinal cohorts, each consisting of 250,000 individuals aged 50 and above. SettingWe started observing them at the beginning of 2004 and 2014, and followed them through the end of 2009 and 2019, respectively. We compared age-specific incidence rates for both cohorts and performed Cox regression models to calculate the hazard ratios (HR) of PD in the second period compared with the first period ten years earlier, adjusted for age, sex, and several prodromal factors, comorbidities, and risk factors of PD. Main outcome and MeasuresMain outcome was the age-specific incidence trends of Parkinsons disease (PD) in two cohorts using routine health claims data ResultsFor each age-group in men and women, we found lower age-specific PD incidence rates in the second period, except for the lowest age-group (50-54) in men. Cox regression analysis demonstrated an overall 20% risk reduction of PD incidence (HR=0.80, 95% confidence interval [0.75-0.86]). Mean age at diagnosis increased in men (+1.98 years) and women (+0,87 years). Stepwise adjustment for prodromal symptoms, comorbidities, and risk factors revealed a 22%-49% risk reduction of PD incidence. Sensitivity analysis considering the competing event of death showed a 48% risk reduction (HR=0.52 [0.48-0.56]), demonstrating the independence of the time trends from changes in death rates. ConclusionOur data show that the risk of PD has decreased over time, and that this decrease is independent of factors such as changes in death rates, age structure, sex, motor and sensory impairments, sleep and psychiatric conditions, comorbidities, and specific risk factors. Key pointsO_ST_ABSQuestionC_ST_ABSWhile several studies have reported on the incidence and prevalence of PD, recent data from Germany have sparked a debate regarding the validity and interpretation of these trends. This study aims to investigate the age-specific incidence rates of Parkinsons Disease (PD) and explore possible explanations for the observed reduced trend in Germany. FindingsWe assessed data from a longitudinal cohort from 2004 to 2009 and 2014 to 2019, respectively. By comparing age-specific incidence rates between the two cohorts we reveal a consistent reduction in the age-specific incidence rates of PD in the second period compared to the first period, except for the lowest age-group (50-54) MeaningWhile several studies have reported on the incidence and prevalence of PD, we identified intriguing trends that warrant further investigation.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- The age at onset of LRRK2 p.Gly2019Ser Parkinson's disease across ancestries and countries of origin 96%
- A comparison between early presentation of dementia with Lewy Bodies, Alzheimer’s disease and Parkinson’s disease: evidence from routine primary care and UK Biobank data 95%
- Development of Parkinson’s disease and its relationship with incidentally-discovered white matter disease and covert brain infarction in a real world cohort 95%
Similar papers in this journal
- Daily steps are a predictor of, but perhaps not a modifiable risk factor for Parkinson's Disease: findings from the UK Biobank 96%
- Genome-wide determinants of mortality and motor progression in Parkinson's disease 96%
- Genome-wide association study of copy number variations in Parkinson's disease 95%
Similar papers in this journal
- The combined effect of lifestyle factors and polygenic scores on age at onset in Parkinson's disease 97%
- Retrospective Case-Control Study of Pre-Diagnosis Observational and Prescription Data in Parkinson's Disease 96%
- Remote monitoring of progression in early Parkinson’s disease: reliability and validity of the Roche PD Mobile Application v2 94%
Similar papers in this journal
- Trajectories of brain volume change over 13 years in chronic schizophrenia. 85%
- Transcriptome Analysis of Human Induced Excitatory Neurons Supports a Strong Effect of Clozapine on Cholesterol Biosynthesis 85%
- Current progress in understanding Schizophrenia using genomics and pluripotent stem cells: A Meta-analytical overview 84%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.